Introducing Tuesdays with Morrisey

Back by popular demand, Adam Morrisey, VP of Sales and Marketing at Shipshape, today announced the launch of his new podcast and newsletter series, Tuesdays with Morrisey. Morrisey aims to connect with entrepreneurs, authors and thought leaders to empower listeners with new insights on topics including leadership, creativity, technology and business.

“This project presents an exciting opportunity to share a passion for continuous learning to inspire listeners to think differently through conversations with innovators striving for significance across work and life. The guests and topics will be diverse, but a central theme is expected to emerge around individuals pursuing their potential in the vocational aspect of their life.” said Morrisey.

In the debut Tuesdays with Morrisey podcast episode, Morrisey spoke with Dr. Patrick J. Murphy, Goodrich Chair of Entrepreneurship and Director of the Entrepreneurship Program at the University of Alabama at Birmingham. Dr. Murphy’s expertise in entrepreneurship is recognized throughout academia and the business world, including his work around social entrepreneurship, the entrepreneurial mindset and comparisons made between 21st century entrepreneurship and the great seafarers from the age of discovery.

Future episodes are expected to feature guests from technology, business, sports and entertainment related industries. To complement the podcast series, Morrisey is launching a monthly newsletter and periodic live events.

Adam currently works for Shipshape, a future-forward technology company working to simplify homeownership. In the community, Adam works closely with Big Brothers Big Sisters, Beyond the Ball and Social Venture Partners.

The first episode will release Tuesday February 15th, make sure to follow along by subscribing here.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More